Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

p16INK4A (CDKN2A) gene deletion is a frequent genetic event in synovial sarcomas.

Subramaniam MM, Noguera R, Piqueras M, Navarro S, López-Guerrero JA, Llombart-Bosch A.

Am J Clin Pathol. 2006 Dec;126(6):866-74.

2.

Cyclin D1 amplification and p16(MTS1/CDK4I) deletion correlate with poor prognosis in head and neck tumors.

Namazie A, Alavi S, Olopade OI, Pauletti G, Aghamohammadi N, Aghamohammadi M, Gornbein JA, Calcaterra TC, Slamon DJ, Wang MB, Srivatsan ES.

Laryngoscope. 2002 Mar;112(3):472-81.

PMID:
12148857
3.
4.

Oncoproteins and proliferation markers in synovial sarcomas: a clinicopathologic study of 19 cases.

Barbashina V, Benevenia J, Aviv H, Tsai J, Patterson F, Aisner S, Cohen S, Fernandes H, Skurnick J, Hameed M.

J Cancer Res Clin Oncol. 2002 Nov;128(11):610-6.

PMID:
12458341
5.
6.

Complex patterns of chromosome 9 alterations including the p16INK4a locus in Wilms tumours.

Natrajan R, Warren W, Messahel B, Reis-Filho JS, Brundler MA, Dome JS, Grundy PE, Vujanic G, Pritchard-Jones K, Jones C.

J Clin Pathol. 2008 Jan;61(1):95-102.

PMID:
17369505
7.

Tissue microarray profiling of primary and xenotransplanted synovial sarcomas demonstrates the immunophenotypic similarities existing between SYT-SSX fusion gene confirmed, biphasic, and monophasic fibrous variants.

Subramaniam MM, Navarro S, Pellin A, López-Guerrero JA, Carda C, Heredia Alvaro JA, Gozalbo Sabater PL, Llombart-Bosch A.

Virchows Arch. 2006 Oct;449(4):435-47.

PMID:
16957934
8.

Detection of SS18-SSX fusion transcripts in formalin-fixed paraffin-embedded neoplasms: analysis of conventional RT-PCR, qRT-PCR and dual color FISH as diagnostic tools for synovial sarcoma.

Amary MF, Berisha F, Bernardi Fdel C, Herbert A, James M, Reis-Filho JS, Fisher C, Nicholson AG, Tirabosco R, Diss TC, Flanagan AM.

Mod Pathol. 2007 Apr;20(4):482-96.

9.

Altered expression of cell cycle regulatory proteins in benign and malignant bone and soft tissue neoplasms.

Bui MM, Bagui TK, Boulware DC, Letson DG, Nasir A, Kaiser HE, Pledger WJ, Coppola D.

In Vivo. 2007 Sep-Oct;21(5):729-37.

10.

Molecular and immunohistochemical analyses of BCL2, KI-67, and cyclin D1 expression in synovial sarcoma.

Krsková L, Kalinová M, Brízová H, Mrhalová M, Sumerauer D, Kodet R.

Cancer Genet Cytogenet. 2009 Aug;193(1):1-8. doi: 10.1016/j.cancergencyto.2009.03.008.

PMID:
19602458
11.

Alterations of the p16INK4a/p14ARF pathway in clear cell sarcoma.

Takahira T, Oda Y, Tamiya S, Yamamoto H, Kawaguchi K, Kobayashi C, Iwamoto Y, Tsuneyoshi M.

Cancer Sci. 2004 Aug;95(8):651-5.

12.

Prognostic significance of p16/cdkn2a loss in pleural malignant mesotheliomas.

Dacic S, Kothmaier H, Land S, Shuai Y, Halbwedl I, Morbini P, Murer B, Comin C, Galateau-Salle F, Demirag F, Zeren H, Attanoos R, Gibbs A, Cagle P, Popper H.

Virchows Arch. 2008 Dec;453(6):627-35. doi: 10.1007/s00428-008-0689-3.

PMID:
18958493
13.

TLE1 as a diagnostic immunohistochemical marker for synovial sarcoma emerging from gene expression profiling studies.

Terry J, Saito T, Subramanian S, Ruttan C, Antonescu CR, Goldblum JR, Downs-Kelly E, Corless CL, Rubin BP, van de Rijn M, Ladanyi M, Nielsen TO.

Am J Surg Pathol. 2007 Feb;31(2):240-6.

PMID:
17255769
14.

The invasion front of human colorectal adenocarcinomas shows co-localization of nuclear beta-catenin, cyclin D1, and p16INK4A and is a region of low proliferation.

Jung A, Schrauder M, Oswald U, Knoll C, Sellberg P, Palmqvist R, Niedobitek G, Brabletz T, Kirchner T.

Am J Pathol. 2001 Nov;159(5):1613-7.

15.

Prospective evaluation of TLE1 as a diagnostic immunohistochemical marker in synovial sarcoma.

Jagdis A, Rubin BP, Tubbs RR, Pacheco M, Nielsen TO.

Am J Surg Pathol. 2009 Dec;33(12):1743-51. doi: 10.1097/PAS.0b013e3181b7ed36.

PMID:
19809272
16.

Frequent p16ink4a inactivation is an early and frequent event of intraductal papillary neoplasm of the liver arising in hepatolithiasis.

Ishikawa A, Sasaki M, Sato Y, Ohira S, Chen MF, Huang SF, Oda K, Nimura Y, Nakanuma Y.

Hum Pathol. 2004 Dec;35(12):1505-14.

PMID:
15619210
17.

Expression profiling in soft tissue sarcomas with emphasis on synovial sarcoma, gastrointestinal stromal tumor, and leiomyosarcoma.

West RB.

Adv Anat Pathol. 2010 Sep;17(5):366-73. doi: 10.1097/PAP.0b013e3181ec7428. Review.

PMID:
20733355
18.

Immunoglobulin G is present in a wide variety of soft tissue tumors and correlates well with proliferation markers and tumor grades.

Chen Z, Huang X, Ye J, Pan P, Cao Q, Yang B, Li Z, Su M, Huang C, Gu J.

Cancer. 2010 Apr 15;116(8):1953-63. doi: 10.1002/cncr.24892.

19.

Fluorescence in situ hybridization for the detection of t(X;18)(p11.2;q11.2) in a synovial sarcoma tissue microarray using a breakapart-style probe.

Terry J, Barry TS, Horsman DE, Hsu FD, Gown AM, Huntsman DG, Nielsen TO.

Diagn Mol Pathol. 2005 Jun;14(2):77-82.

PMID:
15905690
20.

Evaluation of genetic stability of the SYT gene rearrangement by break-apart FISH in primary and xenotransplanted synovial sarcomas.

Subramaniam MM, Noguera R, Piqueras M, Navarro S, Carda C, Pellin A, López-Guerrero JA, Llombart-Bosch A.

Cancer Genet Cytogenet. 2007 Jan 1;172(1):23-8.

PMID:
17175375
Items per page

Supplemental Content

Support Center